These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials. Bloom R; Amber KT An Bras Dermatol; 2017; 92(1):139-141. PubMed ID: 28225977 [TBL] [Abstract][Full Text] [Related]
15. Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate. Hashim N; Bandara D; Tan E; Ilchyshyn A Acta Derm Venereol; 2004; 84(1):90-1. PubMed ID: 15040495 [No Abstract] [Full Text] [Related]
16. The use of plasmapheresis in a 4-year-old boy with toxic epidermal necrosis. Hinc-Kasprzyk J; Polak-Krzemińska A; Głowacka M; Ożóg-Zabolska I Anaesthesiol Intensive Ther; 2015; 47(3):210-3. PubMed ID: 26165239 [TBL] [Abstract][Full Text] [Related]
18. Management of toxic epidermal necrolysis in a 15-year-old girl. Clennett S; Hosking G J Wound Care; 2003 Apr; 12(4):151-4. PubMed ID: 12715488 [TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome due to concomitant use of lamotrigine and valproic acid. Kocak S; Girisgin SA; Gul M; Cander B; Kaya H; Kaya E Am J Clin Dermatol; 2007; 8(2):107-11. PubMed ID: 17428116 [TBL] [Abstract][Full Text] [Related]